These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 20353370)

  • 1. Leflunomide derivative FK778 inhibits production of antibodies in an experimental model of alloreactive T-B cell interaction.
    Ramos-Barrón MA; Gómez-Alamillo C; Santiuste I; Agüeros C; Cosme LS; Benito A; Gimenez T; Merino J; Merino R; Arias M
    Exp Clin Transplant; 2009 Dec; 7(4):218-24. PubMed ID: 20353370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FK778, a powerful new immunosuppressant, effectively reduces functional and histologic changes of chronic rejection in rat renal allografts.
    Pan F; Ebbs A; Wynn C; Erickson L; Jang MS; Crews G; Fisniku O; Kobayashi M; Paul LC; Benediktsson H; Jiang AH
    Transplantation; 2003 Apr; 75(8):1110-4. PubMed ID: 12717186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy of malononitrilamide FK778 with tacrolimus on cell proliferation assays and in rats receiving renal allografts.
    Vu MD; Qi S; Wang X; Jiang W; Ma A; Xu D; Bekersky I; Fitzsimmons WE; Wu J; Chen H
    Transplantation; 2003 May; 75(9):1455-9. PubMed ID: 12792496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FK778 ameliorates post-transplant expression of fibrogenic growth factors and development of chronic rejection changes in rat kidney allografts.
    Rintala JM; Savikko J; Rintala SE; von Willebrand E
    Nephrol Dial Transplant; 2008 Nov; 23(11):3446-55. PubMed ID: 18558624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FK778 controls acute rejection after rat liver allotransplantation showing positive interaction with FK506.
    Yamamoto S; Okuda T; Yamasaki K; Tanaka H; Takemura S; Minamiyama Y; Ikeda K; Hirohashi K; Suehiro S
    Transplant Proc; 2005; 37(1):126-9. PubMed ID: 15808570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel immunosuppressant FK778 inhibits formation of the immunologic Synapse.
    Zeyda M; Geyeregger R; Poglitsch M; Watschinger B; Hörl WH; Stulnig TM; Säemann MD
    Transplant Proc; 2005 May; 37(4):1970-1. PubMed ID: 15919521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FK778 in experimental xenotransplantation: a detailed analysis of drug efficacy.
    Schrepfer S; Deuse T; Koch-Nolte F; Krieger T; Haddad M; Schäfer H; Pelletier MP; Robbins RC; Reichenspurner H
    J Heart Lung Transplant; 2007 Jan; 26(1):70-7. PubMed ID: 17234520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune syndrome after induction of neonatal tolerance to alloantigens. CD4+ T cells from the tolerant host activate autoreactive F1 B cells.
    Merino J; Schurmans S; Duchosal MA; Izui S; Lambert PH
    J Immunol; 1989 Oct; 143(7):2202-8. PubMed ID: 2570803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient T and B cell activation after neonatal induction of tolerance to MHC class II or Mls alloantigens.
    Schurmans S; Brighouse G; Kramer G; Wen L; Izui S; Merino J; Lambert PH
    J Immunol; 1991 Apr; 146(7):2152-60. PubMed ID: 1672344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The malononitrilamide FK778 inhibits activation of NF-kappaB in human dendritic cells.
    Zeyda M; Stuhlmeier KM; Kirsch B; Watschinger B; Hörl WH; Stulnig TM; Säemann MD
    Transplant Proc; 2005 May; 37(4):1968-9. PubMed ID: 15919520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo pharmacokinetic and pharmacodynamic evaluation of the malononitrilamide FK778 in non-human primates.
    Bîrsan T; Dambrin C; Klupp J; Stalder M; Larson MJ; Fitzsimmons WE; Morris RE
    Transpl Int; 2003 May; 16(5):354-60. PubMed ID: 12712238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The new immunosuppressive agent FK778 attenuates neointima formation in an experimental venous bypass graft model.
    de Graaf R; Kloppenburg G; Tintu A; Rouwet E; Kitslaar P; van Hooff J; Bruggeman C; Stassen F
    Vascul Pharmacol; 2009; 50(3-4):83-8. PubMed ID: 19010449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2005 Dr. Gary J. Becker Young Investigator Award: periprocedural oral administration of the leflunomide analogue FK778 inhibits neointima formation in a double-injury rat model of restenosis.
    Jahnke T; Schäfer FK; Bolte H; Rector L; Schäfer PJ; Brossmann J; Fändrich F; Hedderich J; Heller M; Müller-Hülsbeck S
    J Vasc Interv Radiol; 2005 Jul; 16(7):903-10. PubMed ID: 16002499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of FK778 on acute rat renal allograft rejection and expression of platelet-derived growth factor and transforming growth factor-beta.
    Rintala JM; Savikko J; Rintala SE; von Willebrand E
    Transplant Proc; 2006 Oct; 38(8):2719-21. PubMed ID: 17098049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of FK778 alone or in combination with tacrolimus or mTOR inhibitors as an immunomodulator of immunofunctions: in vitro evaluation of T cell proliferation and the expression of lymphocyte surface antigens.
    Millán O; Jiménez O; Fortuna V; Barceló JJ; Brunet M
    Int J Immunopathol Pharmacol; 2006; 19(2):317-30. PubMed ID: 16831299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defects in the regulation of B cell apoptosis are required for the production of citrullinated peptide autoantibodies in mice.
    López-Hoyos M; Marquina R; Tamayo E; González-Rojas J; Izui S; Merino R; Merino J
    Arthritis Rheum; 2003 Aug; 48(8):2353-61. PubMed ID: 12905491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibitors of nucleotide biosynthesis leflunomide, FK778, and mycophenolic acid activate hepatitis B virus replication in vitro.
    Hoppe-Seyler K; Sauer P; Lohrey C; Hoppe-Seyler F
    Hepatology; 2012 Jul; 56(1):9-16. PubMed ID: 22271223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of FK778 on the progression of chronic allograft nephropathy in a rat model.
    Lutz J; Huang H; Deng M; Wagner B; Roos M; Schmaderer C; Strobl M; Heemann U
    Transplantation; 2007 Mar; 83(6):741-6. PubMed ID: 17414707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmunity following neonatal tolerance to alloantigens: role of donor I-A and I-E molecules.
    Kramar G; Schurmans S; Berney M; Izui S; del Giudice G; Lambert PH
    J Autoimmun; 1995 Apr; 8(2):177-92. PubMed ID: 7612147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.